Global Information
회사소개 | 문의 | 비교리스트

세계의 인슐린 펜 시장(2021-2025년)

Global Diabetic Pens Market 2021-2025

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2021년 05월 상품코드 1015696
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,614,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,783,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 인슐린 펜 시장(2021-2025년) Global Diabetic Pens Market 2021-2025
발행일 : 2021년 05월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 인슐린 펜 시장 규모는 2021-2025년간 8% 이상의 CAGR로 확대되고, 36억 5,000만 달러의 성장이 전망됩니다.

인슐린 펜 시장에 관한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개 벤더를 커버하는 벤더 분석을 제공합니다.

시장은 당뇨병 유병률 증가와 당뇨병 자기 관리 교육 프로그램의 이용 가능성에 의해 촉진되고 있습니다. 또한 당뇨병 유병률 증가는 시장 성장도 지지할 것으로 예상됩니다.

세계의 인슐린 펜(Diabetic Pens) 시장을 조사했으며, 시장 개요, 시장 규모, 시장 전망, 고객 상황, 제품별·지역별 분석, 벤더 상황과 벤더 분석 등을 제공합니다.

목차

  • 주요 요약
    • 시장 개요
  • 시장 상황
    • 시장 생태계
    • 밸류체인 분석
  • 시장 규모
    • 시장 정의
    • 시장 부문 분석
    • 시장 규모 : 2020년
    • 시장 전망 : 2020-2025년 예측
  • Five Forces 분석
    • Five Forces 요약
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 경쟁의 위협
    • 시장 상황
  • 제품별 시장 세분화
    • 시장 부문
    • 제품별 비교
    • 재사용 가능 인슐린 펜 : 시장 규모와 예측(2020-2025년)
    • 일회용 인슐린 펜 : 시장 규모와 예측(2020-2025년)
    • 제품별 시장 기회
  • 고객 상황
  • 지역별 상황
    • 지역별 세분화
    • 지역별 비교
    • 북미 : 시장 규모와 예측(2020-2025년)
    • 유럽 : 시장 규모와 예측(2020-2025년)
    • 아시아 : 시장 규모와 예측(2020-2025년)
    • 기타 지역 : 시장 규모와 예측(2020-2025년)
    • 주요 국가
    • 지역별 상황에 의한 시장 기회
    • 시장 성장 촉진요인
    • 시장 과제
    • 시장 동향
  • 벤더 상황
    • 개요
    • 벤더 상황
    • 창조적 파괴 상황
  • 벤더 분석
    • 대상 벤더
    • 벤더의 시장 포지셔닝
    • AstraZeneca Plc
    • Biocon Ltd.
    • Companion Medical Inc.
    • Digital Medics Pvt. Ltd.
    • Eli Lilly and Co.
    • Emperra GmbH E-Health Technologies
    • Jiangsu Delfu medical device Co. Ltd.
    • Novo Nordisk AS
    • Sanofi SA
  • 부록
    • 조사 범위
    • US$ 환율
    • 조사 방법
    • 약어 리스트
KSM 21.07.01

Technavio has been monitoring the diabetic pens market and it is poised to grow by $ 3.65 billion during 2021-2025, progressing at a CAGR of over 8% during the forecast period. Our report on the diabetic pens market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of diabetes and the availability of Diabetes Self-Management Education Programs. In addition, the increasing prevalence of diabetes is anticipated to boost the growth of the market as well.

The diabetic pens market analysis includes the product segment and geographic landscape.

Technavio's diabetic pens market is segmented as below:

By Product

  • Reusable diabetic pens
  • Disposable diabetic pens

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing demand for diabetic injection pens as one of the prime reasons driving the diabetic pens market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on diabetic pens market covers the following areas:

  • Diabetic pens market sizing
  • Diabetic pens market forecast
  • Diabetic pens market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetic pens market vendors that include AstraZeneca Plc, Becton, Dickinson and Co., Biocon Ltd., Companion Medical Inc., Digital Medics Pvt. Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Novo Nordisk AS, and Sanofi SA. Also, the diabetic pens market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Five Forces Summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Reusable diabetic pens - Market size and forecast 2020-2025
    • Disposable diabetic pens - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • AstraZeneca Plc
    • Biocon Ltd.
    • Companion Medical Inc.
    • Digital Medics Pvt. Ltd.
    • Eli Lilly and Co.
    • Emperra GmbH E-Health Technologies
    • Jiangsu Delfu medical device Co. Ltd.
    • Novo Nordisk AS
    • Sanofi SA
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Reusable diabetic pens - Market size and forecast 2020-2025 ($ million)
  • 24: Reusable diabetic pens - Year-over-year growth 2020-2025 (%)
  • 25: Disposable diabetic pens - Market size and forecast 2020-2025 ($ million)
  • 26: Disposable diabetic pens - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity By Geographical Landscape ($ million)
  • 41: North America - Market size and forecast 2020-2025 ($ million)
  • 42: North America - Year-over-year growth 2020-2025 (%)
  • 43: Europe - Market size and forecast 2020-2025 ($ million)
  • 44: Europe - Year-over-year growth 2020-2025 (%)
  • 45: Asia - Market size and forecast 2020-2025 ($ million)
  • 46: Asia - Year-over-year growth 2020-2025 (%)
  • 47: ROW - Market size and forecast 2020-2025 ($ million)
  • 48: ROW - Year-over-year growth 2020-2025 (%)
  • 49: Impact of drivers and challenges
  • 50: Vendor landscape
  • 51: Landscape disruption
  • 52: Industry risks
  • 53: Vendors covered
  • 54: Market positioning of vendors
  • 55: AstraZeneca Plc - Overview
  • 56: AstraZeneca Plc - Product and service
  • 57: AstraZeneca Plc - Key offerings
  • 58: AstraZeneca Plc - Key customers
  • 59: AstraZeneca Plc - Segment focus
  • 60: Becton, Dickinson and Co. - Overview
  • 61: Becton, Dickinson and Co. - Business segments
  • 62: Becton, Dickinson and Co. - Key offerings
  • 63: Becton, Dickinson and Co. - Key customers
  • 64: Becton, Dickinson and Co. - Segment focus
  • 65: Biocon Ltd. - Overview
  • 66: Biocon Ltd. - Business segments
  • 67: Biocon Ltd. - Key offerings
  • 68: Biocon Ltd. - Key customers
  • 69: Biocon Ltd. - Segment focus
  • 70: Companion Medical Inc. - Overview
  • 71: Companion Medical Inc. - Product and service
  • 72: Companion Medical Inc. - Key offerings
  • 73: Companion Medical Inc. - Key customers
  • 74: Companion Medical Inc. - Segment focus
  • 75: Digital Medics Pvt. Ltd. - Overview
  • 76: Digital Medics Pvt. Ltd. - Product and service
  • 77: Digital Medics Pvt. Ltd. - Key offerings
  • 78: Digital Medics Pvt. Ltd. - Key customers
  • 79: Digital Medics Pvt. Ltd. - Segment focus
  • 80: Eli Lilly and Co. - Overview
  • 81: Eli Lilly and Co. - Business segments
  • 82: Eli Lilly and Co. - Key offerings
  • 83: Eli Lilly and Co. - Key customers
  • 84: Eli Lilly and Co. - Segment focus
  • 85: Emperra GmbH E-Health Technologies - Overview
  • 86: Emperra GmbH E-Health Technologies - Product and service
  • 87: Emperra GmbH E-Health Technologies - Key offerings
  • 88: Emperra GmbH E-Health Technologies - Key customers
  • 89: Emperra GmbH E-Health Technologies - Segment focus
  • 90: Jiangsu Delfu medical device Co. Ltd. - Overview
  • 91: Jiangsu Delfu medical device Co. Ltd. - Product and service
  • 92: Jiangsu Delfu medical device Co. Ltd. - Key offerings
  • 93: Jiangsu Delfu medical device Co. Ltd. - Key customers
  • 94: Jiangsu Delfu medical device Co. Ltd. - Segment focus
  • 95: Novo Nordisk AS - Overview
  • 96: Novo Nordisk AS - Business segments
  • 97: Novo Nordisk AS - Key offerings
  • 98: Novo Nordisk AS - Key customers
  • 99: Novo Nordisk AS - Segment focus
  • 100: Sanofi SA - Overview
  • 101: Sanofi SA - Business segments
  • 102: Sanofi SA - Key offerings
  • 103: Sanofi SA - Key customers
  • 104: Sanofi SA - Segment focus
  • 105: Currency conversion rates for US$
  • 106: Research Methodology
  • 107: Validation techniques employed for market sizing
  • 108: Information sources
  • 109: List of abbreviations
Back to Top
전화 문의
F A Q